Six States Issue Statements Regading Medicare Enrollment, Accessa

Medicare is supposed to help older adults and people with disabilities get dependable coverage, not send them into a maze where every turn has a different premium, network, form, and fine-print surprise. But that is exactly why this story matters. In late 2025, six state insurance regulators stepped forward with a pretty direct message: if carriers or producers make approved Medicare products harder to find, harder to enroll in, or less attractive for compensation reasons, they may be crossing the line into unfair trade practices.

That may sound like inside-baseball insurance law, but it has very real consequences. Medicare enrollment is not just a paperwork exercise. It shapes whether a person can keep a trusted doctor, afford prescriptions, use a nearby hospital, or switch out of a plan that no longer fits. Once you add Medicare Advantage, Medigap, Part D, provider networks, annual enrollment windows, and medical underwriting rules, the whole process can feel less like shopping and more like trying to assemble furniture with half the instructions missing.

The reason the six-state action got attention is simple: regulators were not merely complaining about bad vibes. They were zeroing in on specific behaviors. These included removing enrollment applications from websites, discouraging agents from selling certain plans, changing or cutting producer compensation during the plan year, and otherwise steering consumers away from products that were still approved for sale. In other words, the concern was not healthy competition. The concern was whether competition was being rigged at the point where older adults make one of the most important coverage decisions of the year.

Why the six-state statements matter

The six states commonly cited in this wave were Delaware, Idaho, Montana, New Hampshire, North Dakota, and Oklahoma. Their statements were not identical, but the theme was remarkably consistent: Medicare-eligible consumers should be able to access approved products without artificial barriers, and licensed producers should not be pushed away from certain plans through compensation games or hidden distribution tactics.

That matters because Medicare is no tiny corner of the insurance market. Medicare Advantage alone now covers tens of millions of people, and Medicare’s private-plan side has grown steadily over time. At the same time, the number of choices remains large enough to overwhelm almost anyone who is not unusually fond of reading benefit grids for fun. Complexity creates opportunity, and unfortunately not all opportunity is used for consumer good.

State officials were essentially saying: if a carrier files a product, gets it approved, prices it with commissions or support structures in mind, and then quietly makes it hard to access, that is not just clever distribution strategy. It may distort the market, mislead consumers, and interfere with fair enrollment. That is especially important in Medicare because many beneficiaries rely on agents, brokers, or counseling programs to compare options they could never reasonably sort through alone.

What each state was warning about

Idaho

Idaho’s Bulletin No. 25-06 helped set the tone. The bulletin said the Department viewed certain carrier practices as unfair trade practices when they manipulate the market or withhold or deny access to products for Medicare-eligible consumers. Idaho specifically called out practices such as removing enrollment applications, encouraging producers to avoid selling certain products, and changing or discontinuing producer compensation. It also said carriers must keep applications available and accessible, avoid discouraging enrollment, avoid mid-year commission changes, and pay commissions if those commissions were built into the product’s rate development.

Delaware

Delaware followed with a bulletin that sounded equally serious. It framed restricted access to approved Medicare Advantage and Medicare Supplement products as a transparency and accessibility problem, not merely a business preference. Delaware also emphasized that altering or withholding producer compensation, delaying access to tools and materials, or steering consumers away from certain approved products could amount to unfair trade practices. That is a powerful signal because it ties market behavior to the consumer’s practical ability to enroll.

Montana

Montana’s advisory memorandum pushed the same basic warning into the Rocky Mountain air. It said CSI had received reports that some carriers offering Medicare Advantage plans had tried to restrict access by removing enrollment applications, discouraging agents from selling products, or changing or discontinuing compensation during the plan year. Translation: if the path to a plan mysteriously becomes harder to walk the minute the financial incentives change, regulators are noticing.

New Hampshire

New Hampshire joined the group with a bulletin focused on fair marketing and compensation. Public reporting on the bulletin said carriers were reminded that reducing or eliminating producer compensation in ways that interfere with fair access can amount to an unfair insurance trade practice under state law. That gave more momentum to the idea that enrollment access is not only about whether a plan exists on paper, but whether people can actually reach it through normal channels.

North Dakota

North Dakota took a particularly consumer-facing tone. Its department warned that unfair Medicare sales practices could limit seniors’ access to unbiased advice and fair coverage options. The state listed familiar trouble spots: removing applications, discouraging producers from selling specific plans, and changing or discontinuing compensation mid-year. North Dakota also stressed that products should be suitable and in the consumer’s best interest, taking into account prescription drug coverage, provider networks, overall cost, and affordability.

Oklahoma

Oklahoma’s bulletin was similarly blunt. It described the removal of enrollment applications, pressure on producers to avoid certain products, and compensation changes as practices that could manipulate the market and deny access to Medicare-eligible consumers. It went further by saying compensation is not supposed to act as a shock absorber for a bad market or as a profit patch kit. That line lands because it gets to the heart of the issue: consumers should not have fewer choices simply because a carrier no longer likes the economics of a plan that remains approved for sale.

This is really about enrollment and access, not just commissions

It would be easy to misread this story as an argument about whether insurance agents get paid. That is not the main point. The bigger point is that compensation structures can shape what gets presented to beneficiaries, what gets emphasized, and what quietly disappears from practical view. When that happens, enrollment is no longer neutral. It becomes nudged, tilted, and sometimes distorted.

And in Medicare, distorted enrollment has consequences. Medicare Open Enrollment runs from October 15 through December 7 each year, and changes generally take effect January 1. That is a short window for comparing benefits, provider access, prior authorization rules, drug formularies, out-of-pocket costs, and supplemental benefits. Many people rely on someone else to help them sort the options. If the advice channel is narrowed, the plan universe can look smaller than it really is.

That problem gets bigger because access does not end when a person signs an application. Medicare Advantage plans can have narrower provider networks than traditional Medicare. Recent analysis found that Medicare Advantage enrollees, on average, were in plans that included about half of the physicians available to traditional Medicare beneficiaries in their area. So a plan that looks attractive during enrollment can still create real access problems later if a beneficiary finds out favorite doctors, specialists, or hospital-based physicians are out of network.

Why the choice between Medicare Advantage and Medigap can be sticky

One reason regulators are worried is that Medicare choices are not always easy to reverse. Traditional Medicare and Medicare Advantage are not just two flavors of the same ice cream. They operate differently, and switching can come with friction.

For many beneficiaries, Medicare Advantage offers low or zero additional premiums and extra benefits that sound attractive. Original Medicare paired with Medigap often offers broader provider access and more predictable cost-sharing, but the premiums can be higher. The wrinkle is what happens later. If someone enrolls in Medicare Advantage and later decides to return to Original Medicare, getting a Medigap policy may be hard in many states unless the person qualifies for a guaranteed issue right. Outside a handful of states with stronger protections, people switching from Medicare Advantage to traditional Medicare may be denied a Medigap policy because of preexisting conditions, with only limited exceptions.

That makes the initial enrollment choice far more important than many consumers realize. A beneficiary may think, “I’ll just try this plan and switch later if it gets annoying.” Sometimes that works. Sometimes it really does not. And that is precisely why fair access to information at enrollment matters so much. A tilted enrollment process can lock people into paths that are harder to unwind than the marketing materials suggest.

The bigger backdrop: misleading marketing has been on regulators’ radar for years

The six-state statements did not appear out of nowhere. Federal and state policymakers have been circling Medicare marketing issues for years. A Senate Finance Committee investigation described false and misleading Medicare Advantage marketing and fraudulent sales practices as problems that can undermine access to care and trust in the Medicare program. NAIC has also highlighted improper marketing concerns, especially when consumers are sold health coverage with misleading information or not enough detail to understand tradeoffs.

Meanwhile, CMS has continued updating Medicare marketing guidance and broader plan rules, including rules meant to improve beneficiary protections. There is also a larger policy conversation about the role of compensation and incentives in enrollment. Even outside Medicare, CMS guidance has warned that compensation structures that discourage enrollment during protected periods can function like discriminatory marketing practices. State regulators appear to be taking that same basic consumer-protection instinct and applying it to the Medicare marketplace through their unfair-trade authority.

Put plainly, this is a classic case of regulators noticing that the market can be manipulated without anyone technically shouting, “No, you cannot enroll.” If applications disappear, commissions vanish, tools get delayed, or certain products become invisible in practice, the barrier may be subtle, but the effect on consumers can still be very real.

What beneficiaries, caregivers, and agents should take from this

For beneficiaries

Do not assume the easiest plan to find is the best plan for your situation. Compare provider networks, drug coverage, prior authorization requirements, total out-of-pocket exposure, and whether you may want Medigap flexibility later. A low premium can be a good deal, but it can also be a decoy if it narrows access too much.

For caregivers

Ask not only what a parent or spouse is paying today, but what would happen if their doctors change, their drug list grows, or they need frequent specialist care. Coverage that works for a healthy year may feel very different during a complicated one.

For licensed producers

The state bulletins are also a reminder that best-interest duties are not optional decorations. Producers who recommend coverage should be thinking about suitability, affordability, networks, and drug needs, not just whether a plan is the easiest to submit or the most convenient for a carrier.

For everyone

Use unbiased help when possible. State Health Insurance Assistance Programs, or SHIPs, provide free counseling and education for Medicare beneficiaries and their families. These programs matter because Medicare is complicated enough already; nobody needs mystery, pressure, and marketing fog added on top.

Experiences from the Medicare maze

The following experiences are composite examples drawn from the kinds of issues described by regulators, researchers, and counseling programs. They are not one person’s exact story, but they reflect the real patterns behind the six-state warnings.

First, picture a newly eligible Medicare beneficiary who turns 65, retires, and assumes enrollment will be simple. She sees television ads promising extra benefits, lower costs, and an easy sign-up process. What she does not see is how different the plan may feel once she starts using it. She chooses a plan because it is heavily promoted and easy to find online. Months later, she realizes her longtime specialist is out of network and a preferred hospital system is not included. On paper, she enrolled successfully. In reality, access narrowed the moment the plan took effect.

Now think about an adult son helping his father compare coverage. He is trying to do the right thing, but every plan seems to come with a different provider directory, prescription rule, and cost-sharing twist. One local agent tells him only a narrow slice of the available options, not because the other plans are illegal or unavailable, but because those plans are no longer being actively supported or compensated the same way. The family believes it has seen the market. It has really seen a filtered version of the market. That is exactly the kind of quiet distortion state regulators are trying to stop.

Another common experience is the “I’ll switch later” assumption. A beneficiary picks Medicare Advantage because the premium is low and the extras look appealing. A year or two later, health needs change. More specialists are involved, travel becomes harder, and referrals or prior authorization start to feel like an obstacle course. The beneficiary decides Original Medicare with Medigap might be a better fit, only to learn that getting a Medigap policy may require medical underwriting in many states. What looked like a reversible decision suddenly feels sticky. That is why enrollment fairness on day one matters so much on day 700.

Finally, consider the experience of a conscientious independent agent. She wants to compare plans honestly, but during the selling season some products become harder to access, less visible, or less fairly compensated. That does not just hurt her business. It affects what consumers see, hear, and understand. When regulators say markets should not be manipulated through compensation or access barriers, they are not being dramatic. They are trying to preserve a marketplace where an older adult’s coverage options are shaped by need and suitability, not by whichever product a carrier has quietly decided to make easiest to move.

Conclusion

The six-state statements are a warning shot, but they are also a reality check. Medicare enrollment is not just about picking a card for your wallet. It is about whether the system gives people a fair shot at informed choice. When applications disappear, commissions are changed midstream, or certain plans are quietly steered out of view, the damage is not abstract. It lands on seniors, people with disabilities, caregivers, and the professionals trying to guide them.

What makes this story important is that it sits at the intersection of enrollment and access. Enrollment determines the front door. Access determines what happens after you walk through it. The six states were effectively saying both matter, and neither should be manipulated. In a Medicare market that is growing, complex, and increasingly consequential, that is not a minor regulatory footnote. It is a consumer protection issue hiding in plain sight.

SEO Tags